CS9002857A3 - Process for preparing purified albumin from human or animal physiological salt solution - Google Patents
Process for preparing purified albumin from human or animal physiological salt solutionInfo
- Publication number
- CS9002857A3 CS9002857A3 CS902857A CS285790A CS9002857A3 CS 9002857 A3 CS9002857 A3 CS 9002857A3 CS 902857 A CS902857 A CS 902857A CS 285790 A CS285790 A CS 285790A CS 9002857 A3 CS9002857 A3 CS 9002857A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- human
- salt solution
- animal physiological
- physiological salt
- purified albumin
- Prior art date
Links
- 102000009027 Albumins Human genes 0.000 title abstract 3
- 108010088751 Albumins Proteins 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000012266 salt solution Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 230000015961 delipidation Effects 0.000 abstract 1
- 239000003599 detergent Substances 0.000 abstract 1
- 239000003456 ion exchange resin Substances 0.000 abstract 1
- 229920003303 ion-exchange polymer Polymers 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8907586A FR2648048B1 (fr) | 1989-06-08 | 1989-06-08 | Procede de preparation de solutions d'albumine purifiee |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS275600B2 CS275600B2 (en) | 1992-02-19 |
| CS9002857A3 true CS9002857A3 (en) | 1992-02-19 |
Family
ID=9382510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS902857A CS9002857A3 (en) | 1989-06-08 | 1990-06-08 | Process for preparing purified albumin from human or animal physiological salt solution |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6022954A (cs) |
| EP (1) | EP0402205B1 (cs) |
| JP (1) | JP2965623B2 (cs) |
| AT (1) | ATE131490T1 (cs) |
| AU (1) | AU633925B2 (cs) |
| CA (1) | CA2018511C (cs) |
| CS (1) | CS9002857A3 (cs) |
| DD (1) | DD296842A5 (cs) |
| DE (1) | DE69024105T2 (cs) |
| DK (1) | DK0402205T3 (cs) |
| ES (1) | ES2081952T3 (cs) |
| FI (1) | FI101228B1 (cs) |
| FR (1) | FR2648048B1 (cs) |
| GR (1) | GR3018983T3 (cs) |
| HR (1) | HRP920769B1 (cs) |
| HU (1) | HU204282B (cs) |
| NO (1) | NO300041B1 (cs) |
| PL (1) | PL165402B1 (cs) |
| YU (1) | YU48084B (cs) |
| ZA (1) | ZA904315B (cs) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3360315B2 (ja) * | 1992-07-31 | 2002-12-24 | 三菱ウェルファーマ株式会社 | ヒト血清アルブミンの高度精製方法 |
| US5728553A (en) * | 1992-09-23 | 1998-03-17 | Delta Biotechnology Limited | High purity albumin and method of producing |
| AU673485B2 (en) * | 1994-02-16 | 1996-11-07 | Csl Limited | Process for removing endotoxins |
| AUPM388494A0 (en) * | 1994-02-16 | 1994-03-10 | Csl Limited | Process for removing endotoxins |
| WO1997031947A1 (en) * | 1996-02-29 | 1997-09-04 | Delta Biotechnology Limited | High purity albumin production process |
| FR2746030B1 (fr) * | 1996-03-15 | 1998-04-17 | Procede pour eliminer les agents transmissibles non conventionnels (atnc) d'une solution d'albumine | |
| AU731770B2 (en) * | 1996-03-15 | 2001-04-05 | Imedex | Process for removing unconventional transmissible agents from a protein solution |
| DE19831061A1 (de) * | 1998-07-10 | 2000-01-13 | Rotkreuzstiftung Zentrallab | Herstellung von Proteinpräparationen mit verringertem Aggregatgehalt |
| DE19830914C1 (de) * | 1998-07-10 | 1999-06-24 | Centeon Pharma Gmbh | Verfahren zur Herstellung einer Proteinlösung |
| DE19858188A1 (de) * | 1998-12-17 | 2000-07-06 | Centeon Pharma Gmbh | Verfahren zum Auflösen von Albuminflocken in einer Flüssigkeit sowie Einrichtung zur Durchführung des Verfahrens |
| GB9902000D0 (en) | 1999-01-30 | 1999-03-17 | Delta Biotechnology Ltd | Process |
| ES2221817B1 (es) * | 2004-07-26 | 2005-10-01 | Probitas Pharma, S.A. | "soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas". |
| CN110678481B (zh) | 2017-03-16 | 2023-10-31 | 伊沃芙生物制品公司 | 用于纯化白蛋白的方法 |
| US11739166B2 (en) | 2020-07-02 | 2023-08-29 | Davol Inc. | Reactive polysaccharide-based hemostatic agent |
| US12161777B2 (en) | 2020-07-02 | 2024-12-10 | Davol Inc. | Flowable hemostatic suspension |
| US12151045B2 (en) | 2020-12-28 | 2024-11-26 | Davol Inc. | Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2190437B1 (cs) * | 1972-07-05 | 1975-08-08 | Merieux Inst | |
| FR2322871A1 (fr) * | 1975-09-08 | 1977-04-01 | New Zealand Inventions Dev | Procede d'isolement d'albumine |
| SE405549B (sv) * | 1975-10-09 | 1978-12-18 | Pharmacia Fine Chemicals Ab | Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering |
| US4228154A (en) * | 1979-02-26 | 1980-10-14 | Armour Pharmaceutical Company | Purification of plasma albumin by ion exchange chromatography |
| US4315919A (en) * | 1980-10-06 | 1982-02-16 | Edward Shanbrom | Depyrogenation process |
| DE3173208D1 (en) * | 1980-10-06 | 1986-01-23 | Edward Shanbrom | Method of reducing undesirable activities of biological and pharmaceutical products |
| JPS5795997A (en) * | 1980-12-08 | 1982-06-15 | Nippon Sekijiyuujishiya | Removal of admixed protein from albumin-containing solution in presence of water-soluble high polymer |
| FR2543448A1 (fr) * | 1983-04-01 | 1984-10-05 | Rhone Poulenc Spec Chim | Procede de fractionnement du plasma |
-
1989
- 1989-06-08 FR FR8907586A patent/FR2648048B1/fr not_active Expired - Fee Related
-
1990
- 1990-05-31 DE DE69024105T patent/DE69024105T2/de not_active Expired - Fee Related
- 1990-05-31 EP EP90401459A patent/EP0402205B1/fr not_active Expired - Lifetime
- 1990-05-31 AT AT90401459T patent/ATE131490T1/de not_active IP Right Cessation
- 1990-05-31 DK DK90401459.4T patent/DK0402205T3/da active
- 1990-05-31 ES ES90401459T patent/ES2081952T3/es not_active Expired - Lifetime
- 1990-06-05 AU AU56812/90A patent/AU633925B2/en not_active Ceased
- 1990-06-05 ZA ZA904315A patent/ZA904315B/xx unknown
- 1990-06-06 NO NO902499A patent/NO300041B1/no not_active IP Right Cessation
- 1990-06-06 PL PL90285505A patent/PL165402B1/pl not_active IP Right Cessation
- 1990-06-07 CA CA002018511A patent/CA2018511C/en not_active Expired - Lifetime
- 1990-06-07 HU HU903524A patent/HU204282B/hu not_active IP Right Cessation
- 1990-06-07 FI FI902843A patent/FI101228B1/fi active IP Right Grant
- 1990-06-07 DD DD90341411A patent/DD296842A5/de unknown
- 1990-06-08 JP JP2148824A patent/JP2965623B2/ja not_active Expired - Fee Related
- 1990-06-08 CS CS902857A patent/CS9002857A3/cs not_active IP Right Cessation
- 1990-06-08 YU YU112490A patent/YU48084B/sh unknown
-
1991
- 1991-10-11 US US07/774,745 patent/US6022954A/en not_active Expired - Fee Related
-
1992
- 1992-10-01 HR HRP-1124/90A patent/HRP920769B1/xx not_active IP Right Cessation
-
1996
- 1996-02-14 GR GR960400384T patent/GR3018983T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI902843A0 (fi) | 1990-06-07 |
| CA2018511C (en) | 2001-07-31 |
| EP0402205B1 (fr) | 1995-12-13 |
| YU112490A (en) | 1991-10-31 |
| NO300041B1 (no) | 1997-03-24 |
| JP2965623B2 (ja) | 1999-10-18 |
| CS275600B2 (en) | 1992-02-19 |
| AU633925B2 (en) | 1993-02-11 |
| FI101228B (fi) | 1998-05-15 |
| HU204282B (en) | 1991-12-30 |
| HU903524D0 (en) | 1990-10-28 |
| PL165402B1 (pl) | 1994-12-30 |
| NO902499L (no) | 1990-12-10 |
| US6022954A (en) | 2000-02-08 |
| PL285505A1 (en) | 1991-01-28 |
| YU48084B (sh) | 1997-01-08 |
| DE69024105T2 (de) | 1996-07-25 |
| HRP920769B1 (en) | 1998-12-31 |
| GR3018983T3 (en) | 1996-05-31 |
| ATE131490T1 (de) | 1995-12-15 |
| CA2018511A1 (en) | 1990-12-08 |
| HRP920769A2 (hr) | 1994-04-30 |
| DD296842A5 (de) | 1991-12-19 |
| FI101228B1 (fi) | 1998-05-15 |
| DE69024105D1 (de) | 1996-01-25 |
| ZA904315B (en) | 1991-03-27 |
| NO902499D0 (no) | 1990-06-06 |
| HUT54382A (en) | 1991-02-28 |
| FR2648048A1 (fr) | 1990-12-14 |
| FR2648048B1 (fr) | 1994-06-03 |
| EP0402205A1 (fr) | 1990-12-12 |
| ES2081952T3 (es) | 1996-03-16 |
| JPH0381290A (ja) | 1991-04-05 |
| AU5681290A (en) | 1990-12-13 |
| DK0402205T3 (da) | 1996-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS9002857A3 (en) | Process for preparing purified albumin from human or animal physiological salt solution | |
| HU905333D0 (en) | Process for producing cyclic amino-acid derivatives | |
| AU3068289A (en) | Chromatographic separation of plasma proteins | |
| CS56892A3 (en) | Process for industrially preparing standardized extremely pure concentrateof human von willebrand factor, suitable for therapeutical application | |
| IE860305L (en) | Method for purifying antihemophilic factor | |
| BR9004626A (pt) | Processo para preparar um concentrado estavel de complexo de fator viii-fator de von willebrand,concentrado de complexo de fator viii-fator de von willebrand e concentrados de proteina derivados de plasma | |
| HU9301038D0 (en) | Method for producing virus-safe vii factor of high purity | |
| AU652043B2 (en) | Blood coagulation factor X1 concentrate having high specific activity, suitable for therapeutic use, and process for preparing same | |
| IL89351A0 (en) | 4,5,6,7-tetrahydroisothiazolo(4,5-c)pyridines,process for their preparation and pharmaceutical compositions containing them | |
| DE3565535D1 (en) | Process for the preparation of optically active 1,4-dihydropyridines | |
| OA09197A (fr) | "Peptides SDK, leur procédé de préparation ainsi que des compositions thérapeutiques en contenant". |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF00 | In force as of 2000-06-30 in czech republic | ||
| MM4A | Patent lapsed due to non-payment of fee |
Effective date: 20090608 |